Cargando…
Mirk/dyrk1B Kinase in Ovarian Cancer
Mirk/dyrk1B kinase is expressed in about 75% of resected human ovarian cancers and in most ovarian cancer cell lines with amplification in the OVCAR3 line. Mirk (minibrain-related kinase) is a member of the Minibrain/dyrk family of related serine/threonine kinases. Mirk maintains cells in a quiescen...
Autor principal: | Friedman, Eileen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634458/ https://www.ncbi.nlm.nih.gov/pubmed/23528858 http://dx.doi.org/10.3390/ijms14035560 |
Ejemplares similares
-
The Kinase Mirk/dyrk1B: A Possible Therapeutic Target in Pancreatic Cancer
por: Friedman, Eileen
Publicado: (2010) -
Mirk/dyrk1B kinase is upregulated following inhibition of mTOR
por: Deng, Xiaobing, et al.
Publicado: (2014) -
The normal function of the cancer kinase Mirk/dyrk1B is to reduce reactive oxygen species
por: Deng, Xiaobing, et al.
Publicado: (2014) -
The Role of Mirk Kinase in Sarcomas
por: Friedman, Eileen
Publicado: (2011) -
Mirk kinase inhibition targets ovarian cancer ascites
por: Deng, Xiaobing, et al.
Publicado: (2014)